Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:3289-3298, 2006
DOI: 10.2337/db06-0017
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peshavaria, M.
Right arrow Articles by Jetton, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peshavaria, M.
Right arrow Articles by Jetton, T. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of Pancreatic ß-Cell Regeneration in the Normoglycemic 60% Partial-Pancreatectomy Mouse

Mina Peshavaria, Brooke L. Larmie, James Lausier, Basanthi Satish, Aida Habibovic, Violet Roskens, Kyla LaRock, Brian Everill, Jack L. Leahy, and Thomas L. Jetton

From the Division of Endocrinology, Diabetes and Metabolism, University of Vermont, Burlington, Vermont

Address correspondence and reprint requests to Mina Peshavaria, University of Vermont College of Medicine, Department of Medicine, Given C331, Burlington, VT 05405. E-mail: mina.peshavaria{at}uvm.edu

Abbreviations: BCM, ß-cell mass; CPD, common pancreatic duct; Foxa, Forkhead box A; FoxO, forkhead box O; IRS, insulin receptor substrate; pAkt, phospho-activated Akt; PDX, pancreatic duodenal homeobox; Px, partial pancreatectomy

ß-Cell mass is determined by a dynamic balance of proliferation, neogenesis, and apoptosis. The precise mechanisms underlying compensatory ß-cell mass (BCM) homeostasis are not fully understood. To evaluate the processes that maintain normoglycemia and regulate BCM during pancreatic regeneration, C57BL/6 mice were analyzed for 15 days following 60% partial pancreatectomy (Px). BCM increased in Px mice from 2 days onwards and was ~68% of the shams by 15 days, partly due to enhanced ß-cell proliferation. A transient ~2.8-fold increase in the prevalence of ß-cell clusters/small islets at 2 days post-Px contributed substantially to BCM augmentation, followed by an increase in the number of larger islets at 15 days. To evaluate the signaling mechanisms that may regulate this compensatory growth, we examined key intermediates of the insulin signaling pathway. We found insulin receptor substrate (IRS)2 and enhanced-activated Akt immunoreactivity in islets and ducts that correlated with increased pancreatic duodenal homeobox (PDX)1 expression. In contrast, forkhead box O1 expression was decreased in islets but increased in ducts, suggesting distinct PDX1 regulatory mechanisms in these tissues. Px animals acutely administered insulin exhibited further enhancement in insulin signaling activity. These data suggest that the IRS2-Akt pathway mediates compensatory ß-cell growth by activating ß-cell proliferation with an increase in the number of ß-cell clusters/small islets.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. Ackermann Misfeldt, R. H. Costa, and M. Gannon
{beta}-Cell Proliferation, but Not Neogenesis, Following 60% Partial Pancreatectomy Is Impaired in the Absence of FoxM1
Diabetes, November 1, 2008; 57(11): 3069 - 3077.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. Koya, S. Lu, Y.-P. Sun, D. L. Purich, M. A. Atkinson, S.-W. Li, and L.-J. Yang
Reversal of Streptozotocin-Induced Diabetes in Mice by Cellular Transduction With Recombinant Pancreatic Transcription Factor Pancreatic Duodenal Homeobox-1: A Novel Protein Transduction Domain-Based Therapy
Diabetes, March 1, 2008; 57(3): 757 - 769.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. A. Menge, A. Tannapfel, O. Belyaev, R. Drescher, C. Muller, W. Uhl, W. E. Schmidt, and J. J. Meier
Partial Pancreatectomy in Adult Humans Does Not Provoke -Cell Regeneration
Diabetes, January 1, 2008; 57(1): 142 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.